Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.39 Analyst target: $7.78 Upside: 459.71%
ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands.
See the full interactive analysis & chart →Informational only — not investment advice.